MT-II activates melanocortin receptors (MC1R, MC3R, MC4R, and MC5R), stimulating:
1. Melanin production, leading to skin darkening
2. Increased libido and sexual arousal
3. Vasodilation, improving blood flow
Benefits:
1. Increased melanin for UV protection and tanning
2. Potential ED treatment without oral medications
3. Enhanced libido and sexual satisfaction
4. Reduced rosacea symptoms
Administration:
Typically administered via subcutaneous injection (SC).
Research and development:
MT-II has undergone clinical trials, demonstrating:
1. Effective skin darkening and UV protection
2. Improved erectile function in men with ED
3. Enhanced sexual satisfaction in women with FSAD
Dosing guidelines:
Initial dosing: 0.5-1mg, followed by 1-2mg maintenance doses.
Cycles:
Typical cycles range from 4-12 weeks, with breaks in between.
